Fuji, Shigeo http://orcid.org/0000-0001-5118-7950
Kurosawa, Saiko
Inamoto, Yoshihiro
Murata, Tatsunori
Utsunomiya, Atae
Uchimaru, Kaoru
Yamasaki, Satoshi
Inoue, Yoshitaka
Moriuchi, Yukiyoshi
Choi, Ilseung
Ogata, Masao
Hidaka, Michihiro
Yamaguchi, Takuhiro
Fukuda, Takahiro
Funding for this research was provided by:
Japan Agency for Medical Research and Development (19ck0106342h0003)
Narodowe Centrum BadaĆ i Rozwoju (29-A-14)
Article History
Received: 30 August 2019
Revised: 29 October 2019
Accepted: 29 October 2019
First Online: 7 November 2019
Compliance with ethical standards
:
: S.F. received honoraria from Kyowa Hakko Kirin Co., Ltd.; T.M. is an employee of Crecon Medical Assessment Inc, Tokyo, Japan; A.U. received honoraria from Japan Blood Products Organization, Roche Diagnostics, Daiichi Sankyo, Siemens, Bristol-Myers Squibb, Pfizer, Astellas Pharma, Kyowa Hakko Kirin, Novartis Pharma, HUYA Bioscience International, Nippon Shinyaku, Chugai Pharma and Celgene, Immuno-Biological Laboratories and Sumitomo Dainippon Pharma; T.Y. had ownership interests in Statcom Co., Ltd., received consulting fees from Ono Pharmaceutical Co., Ltd., received honoraria from Taiho Pharmaceutical Co., Ltd., and received research funding from Kyowa Hakko Kirin Co., Ltd.; M.H. received research funding from Chugai Pharm Co., Ltd.